Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Scher, H. I.; Graf, R. P.; Schreiber, N. A.; Winquist, E.; McLaughlin, B.; Lu, D.; Orr, S.; Fleisher, M.; Lowes, L.; Anderson, A. K. L.; Wang, Y.; Dittamore, R. V.; Allan, A. L.; Attard, G.; Heller, G.
Abstract Title: Validation of nuclear-localized AR-V7 on circulating tumor cells (CTC) as a treatment-selection biomarker for managing metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 2018 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 6 Suppl.
Meeting Dates: 2018 Feb 8-10
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-20
Language: English
ACCESSION: WOS:000436179500268
DOI: 10.1200/JCO.2018.36.6_suppl.273
PROVIDER: wos
Notes: Meeting Abstract: 273 -- Source: Wos
Altmetric Score
MSK Authors
  1. Glenn Heller
    295 Heller
  2. Martin Fleisher
    237 Fleisher
  3. Howard Scher
    817 Scher